Skin Treatment (Pharmacies) - Burundi

  • Burundi
  • Revenue in the Skin Treatment market is projected to reach US$1.21m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 13.51%, resulting in a market volume of US$2.28m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$3,319.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.09 are generated in 2024.

Key regions: Germany, Europe, South Korea, France, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Skin Treatment (Pharmacies) market in Burundi has been experiencing steady growth in recent years, driven by increasing customer preferences for skincare products and the development of local special circumstances. Customer preferences in the Skin Treatment (Pharmacies) market in Burundi have been shifting towards a greater focus on skincare and the use of specialized products. This trend is in line with global market trends, as consumers become more conscious of the importance of skincare and seek products that can address specific skin concerns. In Burundi, customers are increasingly seeking out skincare products that can effectively treat common skin conditions such as acne, dryness, and hyperpigmentation. They are also showing a preference for natural and organic skincare products, reflecting a growing awareness of the potential harmful effects of certain chemicals commonly found in skincare products. The market is also witnessing a trend towards the adoption of advanced skincare technologies. Customers in Burundi are increasingly seeking out innovative skincare products that incorporate technologies such as microdermabrasion, LED light therapy, and ultrasound. These technologies offer more targeted and effective solutions for various skin concerns, and customers are willing to invest in these products to achieve better results. In addition to changing customer preferences, the Skin Treatment (Pharmacies) market in Burundi is influenced by local special circumstances. One of the key factors driving market growth is the increasing availability of skincare products in pharmacies across the country. Pharmacies in Burundi have expanded their product offerings to include a wide range of skincare products, catering to the growing demand from customers. This increased accessibility has made it easier for customers to find and purchase skincare products, contributing to the overall growth of the market. Another local special circumstance that is impacting the market is the rise of local skincare brands. Burundi has seen the emergence of several local skincare brands that cater specifically to the needs and preferences of the local population. These brands offer products that are formulated with natural and locally sourced ingredients, appealing to customers who prioritize sustainability and supporting local businesses. The presence of these local brands has not only increased competition in the market but has also contributed to the overall growth of the skincare industry in Burundi. Underlying macroeconomic factors, such as economic stability and increasing disposable income, are also contributing to the growth of the Skin Treatment (Pharmacies) market in Burundi. As the economy of Burundi continues to improve, consumers have more purchasing power and are willing to spend on skincare products. This increased disposable income allows customers to invest in high-quality skincare products and treatments, further driving market growth. Overall, the Skin Treatment (Pharmacies) market in Burundi is developing in response to changing customer preferences for skincare products, the availability of advanced skincare technologies, local special circumstances such as the expansion of product offerings in pharmacies and the rise of local skincare brands, and underlying macroeconomic factors such as economic stability and increasing disposable income.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)